Cara Therapeutics (NASDAQ: CARA) has been one of the most exciting biotech stocks to watch in 2017, and the excitement has stemmed from both positive and negative developments. By late June, the stock was up more than 175% year to date. A few weeks later, it had given up half of those gains.
What does the future hold in store for the volatile biotech? Here are two views about where Cara Therapeutics could be five years from now.
Image source: Getty Images.